By Leslie A. Pappas ( February 7, 2023, 5:23 PM EST) -- A Silver Creek Pharmaceuticals shareholder has sued the clinical stage biotech in Delaware's Court of Chancery, claiming that since its CEO resigned in December 2020, the company has stopped communicating to stockholders about its progress and recently withheld material information during a financing round....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.